Timothy Errington
Timothy Errington
Center for Open Science
Verified email at cos.io
Title
Cited by
Cited by
Year
Estimating the reproducibility of psychological science
Open Science Collaboration
Science 349 (6251), 2015
59742015
Badges to acknowledge open practices: A simple, low-cost, effective method for increasing transparency
MC Kidwell, LB Lazarević, E Baranski, TE Hardwicke, S Piechowski, ...
PLoS biology 14 (5), e1002456, 2016
4232016
Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation
JA Smith, CE Poteet-Smith, Y Xu, TM Errington, SM Hecht, DA Lannigan
Cancer research 65 (3), 1027-1034, 2005
3042005
Science forum: An open investigation of the reproducibility of cancer biology research
TM Errington, E Iorns, W Gunn, FE Tan, J Lomax, BA Nosek
Elife 3, e04333, 2014
2292014
The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation
DE Clark, TM Errington, JA Smith, HF Frierson, MJ Weber, DA Lannigan
Cancer research 65 (8), 3108-3116, 2005
1992005
Reproducibility in cancer biology: Making sense of replications
BA Nosek, TM Errington
Elife 6, e23383, 2017
1812017
What is replication?
BA Nosek, TM Errington
PLoS biology 18 (3), e3000691, 2020
762020
Extracellular signal-regulated kinase 7, a regulator of hormone-dependent estrogen receptor destruction
LM Henrich, JA Smith, D Kitt, TM Errington, B Nguyen, AM Traish, ...
Molecular and cellular biology 23 (17), 5979-5988, 2003
692003
Scientific utopia III: Crowdsourcing science
EL Uhlmann, CR Ebersole, CR Chartier, TM Errington, MC Kidwell, ...
Perspectives on Psychological Science 14 (5), 711-733, 2019
562019
Replication study: the CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
SK Horrigan
Elife 6, e18173, 2017
47*2017
Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
C Mantis, I Kandela, F Aird
Elife 6, e17584, 2017
46*2017
Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
F Aird, I Kandela, C Mantis
Elife 6, e21253, 2017
342017
Disease-associated human telomerase RNA variants show loss of function for telomere synthesis without dominant-negative interference
TM Errington, D Fu, JMY Wong, K Collins
Molecular and cellular biology 28 (20), 6510-6520, 2008
312008
Replication Study: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
J Repass
Elife 7, e25801, 2018
29*2018
Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
J Li, M Lam, RPC Biology
eLife 4, e06434, 2015
26*2015
Replication study: melanoma genome sequencing reveals frequent PREX2 mutations
SK Horrigan, P Courville, D Sampey, F Zhou, S Cai
Elife 6, e21634, 2017
23*2017
Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
J Repass, N Maherali, K Owen, RPC Biology
eLife 5, e10012, 2016
23*2016
Registered report: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs
M Phelps, C Coss, H Wang, M Cook, RPC Biology
eLife 5, e12470, 2016
22*2016
Replication study: discovery and preclinical validation of drug indications using compendia of public gene expression data
I Kandela, F Aird
Elife 6, e17044, 2017
20*2017
Registered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
I Khan, J Kerwin, K Owen, E Griner, RPC Biology
Elife 4, e08245, 2015
20*2015
The system can't perform the operation now. Try again later.
Articles 1–20